$Annovis Bio(ANVS.US)$ NEWS Annovis Announces New Publication in a Peer-Reviewed Journal Annovis has published a new article in Biomolecules focusing on Posiphen's pharmacokinetics across different species. The study provides a comprehensive comparison of Posiphen's absorption and metabolism in mice, rats, dogs, and humans. Key findings include fast peak concentration in the plasma, high brain and CSF absorption, rapid clearance from the system, and prolonged retention in the brain. Posiphen's p...
$Annovis Bio(ANVS.US)$News that the FDA is going to clear their drug. Ran out of shares today. Borrow rate is higher than its ever been. Price movement is indicating reversal. Only 3 resistance points which are 6.20, 6.89, and 7.28.
$Annovis Bio(ANVS.US)$Reuters· just Annovis Bio - Believe FDA Will Accept Buntanetap for Symptomatic Relief,Will Allow to Continue Next Pivotal Phase III Study for Disease-Modification
1
2
举报
Benjamin’s :
Are you scaling in ? It’s bottomed no? I no you like the bottoms.
Annovis Bio股票讨论区
NEWS
Annovis Announces New Publication in a Peer-Reviewed Journal
Annovis has published a new article in Biomolecules focusing on Posiphen's pharmacokinetics across different species. The study provides a comprehensive comparison of Posiphen's absorption and metabolism in mice, rats, dogs, and humans. Key findings include fast peak concentration in the plasma, high brain and CSF absorption, rapid clearance from the system, and prolonged retention in the brain. Posiphen's p...
$Junee(JUNE.US)$
$OneMedNet(ONMD.US)$
$旭日升科技(ASTI.US)$
$浩希健康科技(HAO.US)$
Annovis Bio - Believe FDA Will Accept Buntanetap for Symptomatic Relief,Will Allow to Continue Next Pivotal Phase III Study for Disease-Modification
暂无评论